Download FREE Report Sample
Download Free sampleMesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
Mesalamine Market contains market size and forecasts of Mesalamine in global, including the following market information:
Global Mesalamine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Mesalamine Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Mesalamine companies in 2021 (%)
The global Mesalamine market was valued at 161 million in 2021 and is projected to reach US$ 198.9 million by 2028, at a CAGR of 3.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity ? 97% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mesalamine include Syntese A/S, Divis Laboratories, Cambrex Corporation, Ipca Laboratories, Hangzhou Brother, PharmaZell, Lianyungang Fengheng Biopharm, Lasa Loboratory and Erregierre SpA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Mesalamine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mesalamine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Mesalamine Market Segment Percentages, by Type, 2021 (%)
Purity ? 97%
Purity ? 98%
Purity ? 99%
Global Mesalamine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Mesalamine Market Segment Percentages, by Application, 2021 (%)
Mesalazine Tablets
Mesalazine Capsules
Others
Global Mesalamine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Mesalamine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mesalamine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Mesalamine revenues share in global market, 2021 (%)
Key companies Mesalamine sales in global market, 2017-2022 (Estimated), (MT)
Key companies Mesalamine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
Hangzhou Brother
PharmaZell
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
